• Bsa I (RNase-free): Practical DNA Workflow Guide

  2026-09-16

  Bsa I (RNase-free) provides sequence-directed DNA cleavage for cloning, DNA manipulation, and other molecular biology research workflows where RNA degradation should be minimized. It is intended for scientific research use only and should not be used for diagnostic, clinical, or medical applications.

• Arsenic Neurotoxicity, MMP-2/9, and BBB Injury

  2026-09-16

  A 2024 mouse study connects chronic sodium arsenite exposure with cognitive impairment through MMP-2/MMP-9-associated blood–brain barrier disruption, tight-junction loss, and hippocampal neuronal apoptosis. Its pharmacological rescue design supports a mechanistic role for barrier-degrading pathways while also illustrating why doxycycline-based intervention cannot, by itself, establish target-specific causality.

• NSP15 Screening Highlights Thymopentin and Oleuropein

  2026-09-15

  The reference study combined structure-based virtual screening with molecular dynamics simulations to identify thymopentin and oleuropein as leading natural-product binders of SARS-CoV-2 NSP15. Its main contribution is a computational prioritization framework for an immune-evasion target, while the absence of biochemical and cellular validation means the compounds remain hypotheses for follow-up rather than established antivirals.

• Apigenin Workflows for HDAC Research

  2026-09-15

  Apigenin supports a practical bridge between malignant mesothelioma growth studies and network-guided neurodegeneration assays. This workflow-focused guide covers formulation, dose selection, HDAC-linked apoptosis, reactive oxygen species, DNA damage, and troubleshooting for more reproducible experiments.

• Entecavir (BMS200475) HBV Assay Workflow

  2026-09-14

  Build reproducible Entecavir assays around dose-response profiling, resistant HBV models, and orthogonal viral-DNA readouts. This practical guide separates cell-based workflow recommendations from clinical resistance evidence so researchers can improve assay sensitivity without overinterpreting translational results.

• PP2A, Autophagy, and Candida Biofilm Resistance

  2026-09-14

  The reference study identifies PP2A catalytic subunit PPH21 as a regulator of Candida albicans biofilm formation and antifungal resistance through ATG protein phosphorylation and autophagy. Its genetic, pharmacologic, and mouse infection experiments connect PP2A-dependent autophagy with reduced treatment efficacy, while also defining important limits for translating the findings to other Candida species and infection models.

• TCEP Hydrochloride for DPC Proteolysis Assays

  2026-09-13

  TCEP hydrochloride provides odorless, water-compatible disulfide reduction for protein preparation, digestion, and structural assays. When applied carefully around SPRTN experiments, it helps separate redox-dependent sample effects from ubiquitin-dependent DNA-protein crosslink proteolysis.

• Dynasore for Reliable Cell Assays

  2026-09-12

  This scenario-based guide explains how Dynasore, SKU A1605, can support controlled studies of dynamin-dependent endocytosis while protecting cell viability and cytotoxicity assay interpretation. It combines product handling details with literature-based guidance for dosing, controls, storage, and cross-domain data interpretation.

• Methylprednisolone Workflows for Bone Inflammation

  2026-09-11

  Build reproducible Methylprednisolone studies that connect macrophage cytokine responses with osteoclast, imaging, and tissue-level outcomes. This workflow emphasizes solvent control, exposure timing, and translational alignment with glucocorticoid-induced osteonecrosis research.

• PPARγ, Macrophage Polarization, and DSS Colitis

  2026-09-11

  The reference study shows that PPARγ activation mitigates DSS-induced intestinal inflammation by shifting macrophages away from an M1 phenotype and toward an M2-associated state through coordinated STAT-1/STAT-6 signaling. Its combined cell and mouse experiments connect receptor activity, macrophage polarization, epithelial barrier preservation, and clinical disease measures, while also defining important limits for translation.

• SmD2 Acetylation Links Splicing to PARP Sensitivity

  2026-09-10

  This 2024 Nature Communications study identifies SmD2 acetylation as a regulatory link between core spliceosome function, BRCA1/FANC cassette-exon usage, DNA-damage responses, and PARP inhibitor sensitivity in hepatocellular carcinoma. Its findings support investigating HDAC2-directed epigenetic modulation, including Romidepsin plus olaparib, as a strategy for exposing a therapeutically actionable vulnerability in HCC models.

• Rimonabant (SR141716) in CB1 Research

  2026-09-10

  Rimonabant (SR141716) provides a selective CB1 blockade strategy for separating endocannabinoid signaling from appetite, inflammatory, and pain-related phenotypes. This workflow-focused guide shows how to prepare, deploy, and troubleshoot the compound while using the latest terpene pain research to sharpen mechanism-of-action controls.

• Albiflorin Inhibits RCC via EGFR/MAPK Signaling

  2026-09-09

  This study combines cell-based assays, network pharmacology, molecular docking, and pathway rescue experiments to show that albiflorin suppresses renal cell carcinoma proliferation and migration. Its findings prioritize EGFR/MAPK signaling and MMP9/FGF2 regulation as testable mechanisms, while also defining important limits for translation beyond cultured cells.

• Rocket-Like Nanomedicine Restores PDAC Stromal Homeostasis

  2026-09-09

  The reference study develops an acid-responsive, multistage nanomedicine that combines stromal remodeling with gemcitabine delivery for pancreatic ductal adenocarcinoma. Its central innovation is sequential release of halofuginone and IPR-803 to reduce stromal resistance and improve intratumoral access to gemcitabine, producing marked tumor regression in a pancreatic cancer mouse model.

• Paclitaxel (Taxol) in Cancer Research Workflows

  2026-09-09

  Build reproducible cancer research assays around Paclitaxel (Taxol), from DMSO stock preparation and dose finding to cell-cycle and microtubule readouts. This workflow also uses Paclitaxel as a mechanistically distinct comparator when studying IL-6/GP130 signaling and bazedoxifene response.

8432 records 1/563 page Next 12345 下5页 Last page